Compare CPBI & CSBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CPBI | CSBR |
|---|---|---|
| Founded | 2023 | 1985 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 72.8M | 82.7M |
| IPO Year | 2023 | 2015 |
| Metric | CPBI | CSBR |
|---|---|---|
| Price | $17.49 | $5.91 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 2.1K | ★ 5.2K |
| Earning Date | 06-12-2026 | 03-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 161.11 |
| EPS | ★ 0.80 | N/A |
| Revenue | N/A | ★ $2,900,000.00 |
| Revenue This Year | N/A | $4.84 |
| Revenue Next Year | N/A | $11.51 |
| P/E Ratio | $21.78 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $14.52 | $5.50 |
| 52 Week High | $17.89 | $9.63 |
| Indicator | CPBI | CSBR |
|---|---|---|
| Relative Strength Index (RSI) | 51.76 | 49.16 |
| Support Level | $17.37 | $5.50 |
| Resistance Level | $17.84 | $6.28 |
| Average True Range (ATR) | 0.10 | 0.25 |
| MACD | -0.00 | 0.00 |
| Stochastic Oscillator | 54.30 | 34.79 |
Central Plains Bancshares Inc operates as the bank holding company for Home Federal Savings and Loan Association of Grand Island that provides mortgage, consumer, commercial real estate, and commercial loans, The bank business consists mainly of accepting deposits from the general public and investing those deposits, together with funds generated from operations, in one- to four-family residential mortgage loans secured by properties located in primary market area, as well as commercial real estate loans.
Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment namely Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). Its POS business assists physicians in developing personalized treatment options for their cancer patients through tumor-specific data obtained from drug panels and related personalized oncology services. The TOS business assists pharmaceutical and biotechnology companies with their drug development process and offers studies or license tumors for use in studies. The company's revenue is majorly derived from research services.